Data Presented on Myasthenia Gravis at the 2026 American Academy of Neurology Meeting by Madaline Spencer| Published on: May 28, 2026

Data Presented on Myasthenia Gravis at the 2026 American Academy of Neurology Meeting by Madaline Spencer| Published on: May 28, 2026 Omar Sinno, MD, US Medical Strategy Lead for Rare Disease at UCB Pharma, discusses data presented on myasthenia gravis (MG) at the 2026 American Academy of Neurology meeting. https://checkrare.com/data-presented-on-myasthenia-gravis-at-the-2026-american-academy-of-neurology-meeting/